- Release Date: 06/07/22 09:50
- Summary: First Patient dosed in ATH434 Phase 2 Clinical Trial
- Price Sensitive: Yes
- Download Document 202.37KB
- Forums
- ASX - By Stock
- ATH
- Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial
ATH
alterity therapeutics limited
Add to My Watchlist
3.57%
!
1.4¢

Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
-0.001(3.57%) |
Mkt cap ! $124.3M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.3¢ | $28.85K | 2.145M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 800469 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 472 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
45 | 24650817 | 0.013 |
40 | 18288569 | 0.012 |
19 | 9505237 | 0.011 |
36 | 16103355 | 0.010 |
15 | 7351877 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 1797565 | 8 |
0.015 | 20702077 | 12 |
0.016 | 4637555 | 15 |
0.017 | 7408424 | 11 |
0.018 | 11761167 | 21 |
Last trade - 15.59pm 12/08/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |